Cite
HARVARD Citation
Master, Z. et al. (2017). Industry Responsibilities in Tackling Direct‐to‐Consumer Marketing of Unproven Stem Cell Treatments. Clinical pharmacology & therapeutics. 102 (2), pp. 177-179. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Master, Z. et al. (2017). Industry Responsibilities in Tackling Direct‐to‐Consumer Marketing of Unproven Stem Cell Treatments. Clinical pharmacology & therapeutics. 102 (2), pp. 177-179. [Online].